External Contributor
About
Many authors are contributing to Labiotech.eu. If you want to join them, feel free to reach out to us with your article ideas.
Articles by External Contributor
In Depth 13 Jun 2023
Abeta-targeting antibodies pave the way for Alzheimer’s disease vaccines
By Dr. Andrea Pfeifer, CEO of AC Immune SA The clinical success we’ve recently seen with two monoclonal antibodies that target the protein amyloid beta (Abeta) has provided hope for patients, a significant boost to the sector but also a strong validation of the “amyloid hypothesis”: removing Abeta plaques is a valid therapeutic strategy for […]
News and Trends 13 Jun 2023
How AI can advance research and treatment of CNS disorders
By Xiao Xu, senior research fellow, Cerevance The combination of large-scale biological datasets and developments in artificial intelligence (AI) has revolutionized our understanding and treatment of central nervous system (CNS) disorders. By leveraging AI’s computational power, researchers have been able to interrogate diverse datasets to provide insights into disease mechanisms, discover novel therapeutic compounds, detect […]
Opinion 13 Jun 2023
How will European Commission proposals on data exclusivity and the bolar exemption affect pharma companies?
By Andrew Sharples, co-head of EIP’s UK litigation team In April, the European Commission published proposed legislation (specifically a new Regulation and a new Directive) aimed at reforming EU legislation in relation to pharmaceuticals. These proposals, if adopted, will affect pharmaceutical regulation in several ways. In relation to IP specifically, they will affect the periods […]
Assessing the EU Pharmaceutical Package – Positives, negatives and the impact on smaller pharma and biotech companies
News and Trends 10 May 2023
Delivering on the need for vector innovation in genetic medicine
By Tuyen Ong, CEO Ring Therapeutics, CEO-Partner Flagship Pioneering Gene therapy is a life-changing class of medicine that can treat patients with once intractable diseases. While revolutionary, significant limitations remain for the vectors that carry them. Viruses are masters at delivering genetic material to the nucleus of the organisms they infect, and because of this, […]
News and Trends 10 May 2023
Cell rejuvenation for age-related diseases
By Sharon Rosenzweig-Lipson, CSO, Life Biosciences Cellular rejuvenation is quickly becoming a hot topic in the development of novel therapeutic modalities for a range of diseases. The leading approaches to cellular rejuvenation currently in development utilize epigenetic reprogramming to achieve this goal. Epigenetics is the study of how positive and negative lifestyle factors (exercise, smoking, […]
Opinion 9 May 2023
Where is innovation needed in cell therapy?
By Dr Ryan Roberts, cell processing lead at Cellular Origins Despite the rapidly emerging innovations in the field of cell and gene therapy, bottlenecks in cell therapy manufacturing processes are preventing these transformative medicines from reaching patients. There are several broad challenges to the scalability and affordability of cell therapies, including a reliance on manual […]
Separation and analysis of empty and filled capsids during viral vector production
How is Quantoom Biosciences’ Ntensify™ technology changing mRNA production?
Opinion 26 Apr 2023
Can mRNA vaccines tackle multiple diseases?
By Dr. Myriam Mendila, chief development officer of CureVac World Immunization Week is April 24-30, and it’s an important week to highlight the action needed and to promote the use of vaccines to protect people around the world, of all ages, against infectious diseases. World Immunization Week aims to promote the use of vaccines to […]
Opinion 26 Apr 2023
How to address declining vaccination rates in older adults
By Philip Dormitzer, global head of vaccines research and development, GSK The vaccines landscape has changed greatly over the last few years in light of the COVID-19 pandemic. New technologies have been applied at scale, innovative vaccine programs rolled out, and supply chains rearranged to help tackle global health challenges. But, while innovation has improved […]
ADVERTISEMENT